These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 16164489

  • 1. Dose evaluation for long-term magnesium treatment in aneurysmal subarachnoid haemorrhage.
    van Norden AG, van den Bergh WM, Rinkel GJ.
    J Clin Pharm Ther; 2005 Oct; 30(5):439-42. PubMed ID: 16164489
    [Abstract] [Full Text] [Related]

  • 2. Magnesium therapy after aneurysmal subarachnoid haemorrhage a dose-finding study for long term treatment.
    van den Bergh WM, Albrecht KW, Berkelbach van der Sprenkel JW, Rinkel GJ.
    Acta Neurochir (Wien); 2003 Mar; 145(3):195-9; discussion 199. PubMed ID: 12632115
    [Abstract] [Full Text] [Related]

  • 3. The effect of intravenous magnesium therapy on serum and urine levels of potassium, calcium, and sodium in patients with ischemic heart disease, with and without acute myocardial infarction.
    Rasmussen HS, Cintin C, Aurup P, Breum L, McNair P.
    Arch Intern Med; 1988 Aug; 148(8):1801-5. PubMed ID: 3041940
    [Abstract] [Full Text] [Related]

  • 4. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
    Schmid-Elsaesser R, Kunz M, Zausinger S, Prueckner S, Briegel J, Steiger HJ.
    Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
    [Abstract] [Full Text] [Related]

  • 5. Magnesium sulfate in the management of patients with aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, dose-adapted trial.
    Muroi C, Terzic A, Fortunati M, Yonekawa Y, Keller E.
    Surg Neurol; 2008 Jan; 69(1):33-9; discussion 39. PubMed ID: 18054611
    [Abstract] [Full Text] [Related]

  • 6. Assessment of the efficacy and safety of intravenous conivaptan in patients with euvolaemic hyponatraemia: subgroup analysis of a randomized, controlled study.
    Verbalis JG, Zeltser D, Smith N, Barve A, Andoh M.
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):159-68. PubMed ID: 18034777
    [Abstract] [Full Text] [Related]

  • 7. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 8. Effect of magnesium treatment and glucose levels on delayed cerebral ischemia in patients with subarachnoid hemorrhage: a substudy of the Magnesium in Aneurysmal Subarachnoid Haemorrhage trial (MASH-II).
    Leijenaar JF, Dorhout Mees SM, Algra A, van den Bergh WM, Rinkel GJ, MASH-II Study Group.
    Int J Stroke; 2015 Oct; 10 Suppl A100():108-12. PubMed ID: 26502971
    [Abstract] [Full Text] [Related]

  • 9. Erythropoietin in patients with aneurysmal subarachnoid haemorrhage: a double blind randomised clinical trial.
    Springborg JB, Møller C, Gideon P, Jørgensen OS, Juhler M, Olsen NV.
    Acta Neurochir (Wien); 2007 Nov; 149(11):1089-101; discussion 1101. PubMed ID: 17876497
    [Abstract] [Full Text] [Related]

  • 10. Hypocalcaemia may reduce the beneficial effect of magnesium treatment in aneurysmal subarachnoid haemorrhage.
    Van de Water JM, Van den Bergh WM, Hoff RG, Algra A, Rinkel GJ.
    Magnes Res; 2007 Jun; 20(2):130-5. PubMed ID: 18062586
    [Abstract] [Full Text] [Related]

  • 11. Effect of exenatide on 24-hour blood glucose profile compared with placebo in patients with type 2 diabetes: a randomized, double-blind, two-arm, parallel-group, placebo-controlled, 2-week study.
    Schwartz SL, Ratner RE, Kim DD, Qu Y, Fechner LL, Lenox SM, Holcombe JH.
    Clin Ther; 2008 May; 30(5):858-67. PubMed ID: 18555933
    [Abstract] [Full Text] [Related]

  • 12. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
    Aurora SK, Gawel M, Brandes JL, Pokta S, Vandenburgh AM, BOTOX North American Episodic Migraine Study Group.
    Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
    [Abstract] [Full Text] [Related]

  • 13. Achieved serum magnesium concentrations and occurrence of delayed cerebral ischaemia and poor outcome in aneurysmal subarachnoid haemorrhage.
    Dorhout Mees SM, van den Bergh WM, Algra A, Rinkel GJ.
    J Neurol Neurosurg Psychiatry; 2007 Jul; 78(7):729-31. PubMed ID: 17135457
    [Abstract] [Full Text] [Related]

  • 14. Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial.
    Dorhout Mees SM, Algra A, Vandertop WP, van Kooten F, Kuijsten HA, Boiten J, van Oostenbrugge RJ, Al-Shahi Salman R, Lavados PM, Rinkel GJ, van den Bergh WM, MASH-2 Study Group.
    Lancet; 2012 Jul 07; 380(9836):44-9. PubMed ID: 22633825
    [Abstract] [Full Text] [Related]

  • 15. Magnesium and headache after aneurysmal subarachnoid haemorrhage.
    Dorhout Mees SM, Bertens D, van der Worp HB, Rinkel GJ, van den Bergh WM.
    J Neurol Neurosurg Psychiatry; 2010 May 07; 81(5):490-3. PubMed ID: 19828484
    [Abstract] [Full Text] [Related]

  • 16. Effects of oral magnesium supplementation on glycaemic control in Type 2 diabetes: a meta-analysis of randomized double-blind controlled trials.
    Song Y, He K, Levitan EB, Manson JE, Liu S.
    Diabet Med; 2006 Oct 07; 23(10):1050-6. PubMed ID: 16978367
    [Abstract] [Full Text] [Related]

  • 17. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
    van den Bergh WM, Mees SM, Rinkel GJ.
    Neurosurgery; 2006 Nov 07; 59(5):E1152; author reply E1152. PubMed ID: 17143226
    [No Abstract] [Full Text] [Related]

  • 18. Biologic effects of simvastatin in patients with aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled randomized trial.
    Vergouwen MD, Meijers JC, Geskus RB, Coert BA, Horn J, Stroes ES, van der Poll T, Vermeulen M, Roos YB.
    J Cereb Blood Flow Metab; 2009 Aug 07; 29(8):1444-53. PubMed ID: 19458605
    [Abstract] [Full Text] [Related]

  • 19. Pilot randomised double-blind controlled trial of high-dose spironolactone in critically ill patients receiving a frusemide infusion.
    Apte Y, Bellomo R, Warrillow S, Goldsmith D, Gillies M, McGain F.
    Crit Care Resusc; 2008 Dec 07; 10(4):306-11. PubMed ID: 19049481
    [Abstract] [Full Text] [Related]

  • 20. Magnesium sulphate in the management of patients with aneurysmal subarachnoid haemorrhage: a meta-analysis of prospective controlled trials.
    Ma L, Liu WG, Zhang JM, Chen G, Fan J, Sheng HS.
    Brain Inj; 2010 Dec 07; 24(5):730-5. PubMed ID: 20334471
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.